Skip to main content

Are you Dr. Hung?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 72 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Jeffrey Hung, MD is an Interventional Radiologist in Sellersville, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania, New Jersey, and District of Columbia. He is affiliated with Grand View Health, Pottstown Hospital, and Temple Health—Chestnut Hill Hospital.

Education & Training

  • Howard University
    Howard UniversityFellowship, Vascular and Interventional Radiology, 1998 - 1999
  • Temple University Hospital
    Temple University HospitalResidency, Radiology-Diagnostic, 1994 - 1998
  • West Virginia University School of Medicine
    West Virginia University School of MedicineClass of 1994

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 1999 - 2025
  • PA State Medical License
    PA State Medical License 1995 - 2024
  • DC State Medical License
    DC State Medical License 1998 - 2000
  • American Board of Radiology Diagnostic Radiology

Publications & Presentations

PubMed

Press Mentions

  • Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market by Scale of Operation, Type of Vector, Application Area, Therapeutic Area, and Geographical Regions : Industry Trends and Global Forecasts, 2021-2030
    Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market by Scale of Operation, Type of Vector, Application Area, Therapeutic Area, and Geographical Regions : Industry Trends and Global Forecasts, 2021-2030May 28th, 2021
  • Viral and Non-Viral Vector Manufacturing Market Is Anticipated to Grow at an Annualized Rate of over 20%
    Viral and Non-Viral Vector Manufacturing Market Is Anticipated to Grow at an Annualized Rate of over 20%September 4th, 2020
  • Altimmune CEO on the Biotech’s Covid-19 Strategy, Vaccine Development
    Altimmune CEO on the Biotech’s Covid-19 Strategy, Vaccine DevelopmentAugust 10th, 2020
  • Join now to see all

Hospital Affiliations